𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine: Progress in the Treatment of Pancreatic Cancer

✍ Scribed by Heinemann, Volker

Book ID
120556484
Publisher
S. Karger AG
Year
2000
Tongue
English
Weight
188 KB
Volume
60
Category
Article
ISSN
0030-2414

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combined gemcitabine and radioimmunother
Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer
✍ Thomas M. Cardillo; Rosalyn Blumenthal; Zhiliang Ying; David V. Gold πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 116 KB πŸ‘ 1 views

## Abstract MAb‐PAM4 is an anti‐MUC1 antibody that has been shown to be reactive with 85% of pancreatic adenocarcinomas with no reactivity with normal pancreas or other tissues. Initial clinical studies have shown excellent targeting with high tumor/nontumor ratios. Gemcitabine, an analog of deoxyc